Skip to content

Released Aug 9, 2016, before the open

10-Q filed Aug 9, 2016, 40 days after period end · 0001144204-16-117433

Q2 2016 · 10-Q
Revenue—
Net Income-$5.76MN/M vs Q2 2015N/M vs Q1 2016
EPS Diluted-$0.32N/M vs Q2 2015N/M vs Q1 2016
Operating Income-$5,815,120N/M
Operating Cash Flowderived-$5,176,218N/M
Free Cash Flowderived-$5,196,666N/M

What the release said

The release

Same quarter

MetricQ2 2016Q2 2015Q2 2014Q2 2013
Net Income-$5.76M-$4.25M-$6.97M-$1.37M
EPS Diluted-$0.32-$0.26-$0.55-$0.31

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Lipocine Inc. · CIK 1535955 · Engraved from SEC EDGAR